Therapeutic Development in COVID-19

Link to article at PubMed

Adv Exp Med Biol. 2021;1318:435-448. doi: 10.1007/978-3-030-63761-3_25.


Since the outbreak of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2, the disease has spread rapidly worldwide and developed into a global pandemic, causing a significant impact on the global health system and economic development. Scientists have been racing to find effective drugs and vaccines for the treatment and prevention of COVID-19. However, due to the diversity of clinical manifestations caused by COVID-19, no standard antiviral regimen beyond supportive therapy has been established. Ongoing clinical trials are underway to evaluate the efficacy of drugs that primarily act on the viral replication cycle or enhanced immunity of patients. This chapter will summarize the currently used antiviral and adjuvant therapies in clinical practice and provide a theoretical basis for the future treatment of COVID-19.

PMID:33973193 | DOI:10.1007/978-3-030-63761-3_25

Leave a Reply

Your email address will not be published.